Johnson & Johnson is an American multinational medical devices,
pharmaceutical and consumer packaged goods manufacturer founded in 1886.
Its common stock is a component of the Dow Jones Industri...
Mar 29, 2013 ... J&J Wins Approval for First in New Class of Diabetes Drugs. Johnson ... “I worry
its use in women will be somewhat minimal,” Butler said.
Apr 19, 2016 ... (NYSE:LLY) and will almost certainly turn out positive for Johnson & Johnson (
NYSE:JNJ). ... This drug was the latest SGLT2 to win approval in the U.S., but that
was ... Maybe it's the diabetes care relationships built through its ...
Mar 30, 2013 ... The drug, Invokana, will be sold by Johnson & Johnson and treats patients with
type 2 diabetes in a new way, by causing blood sugar to be ...
Apr 1, 2013 ... "Patients with type 2 diabetes struggle managing their blood sugar, and nearly
half of ... Janssen will partner with other Johnson & Johnson companies focused
on ..... (BIIB) Wins FDA Approval for Blockbuster Oral MS Drug.
Apr 5, 2013 ... The FDA has approved Invokana (canagliflozin), the first drug in a new class of ...
As the first company to win FDA approval, Johnson & Johnson has a leg up on
industry rivals developing their own ... More details on the studies will be
presented at the American Diabetes Association annual meeting in June.
The FDA recently gave its approval to several new drugs that are part of a new
class of ... The first of these was Johnson & Johnson's drug canagliflozin, which is
... As is the case with all new diabetes drugs, now that the drug is approved, drug
... the rest of the side effects of this new class of drugs won't begin to bec...
Mar 29, 2013 ... The FDA on Friday cleared Johnson & Johnson's Invokana (canaglifozin), ... "I
worry its use in women will be somewhat minimal," Butler said. ... Finance); J&J
Wins U.S. Approval for First in Diabetes Drug Class - (Bloomberg) ...
Mar 29, 2013 ... U.S. FDA approves Johnson & Johnson diabetes drug, canagliflozin ... from
Johnson & Johnson, making it the first in its class to be approved in ...
Republicans win Obamacare legal challenge, add to insurer concerns | Video.
Feb 4, 2016 ... Johnson & Johnson, continuing its long quest for a Type 1 diabetes ...
Researchers at universities and other drug companies also are working toward a
diabetes cure, ... “We wanted to hedge our bets to make sure we would win in this
... If that goes well, in the next round of testing a few dozen patients will ...